Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Fennec Pharmaceuticals Inc (FRX.TO)

Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fennec Pharmaceuticals Inc 68 TW Alexander Drive PO Box 13628 Research Triangle Park NC 27709 USA

https://www.fennecpharma.com P: 919-636-4530

Description:

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Key Statistics

Overview:

Market Capitalization, $K 222,949
Shares Outstanding, K 27,322
Annual Sales, $ 21,252 K
Annual Net Income, $ -16,045 K
Last Quarter Sales, $ 25,377 K
Last Quarter Net Income, $ 12,837 K
60-Month Beta 0.87
% of Institutional Shareholders 13.71%

Growth:

1-Year Return -34.25%
3-Year Return 11.78%
5-Year Return 31.61%

Per-Share Information:

Most Recent Earnings 0.41 on 05/14/24
Next Earnings Date 08/01/24
Earnings Per Share ttm 0.04
EPS Growth vs. Prev Year -103.06%
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 09/05/14

FRX.TO Ratios

Ratio
Price/Earnings ttm 148.48
Price/Earnings forward 6.80
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % 6.25%
Profit Margin % -75.50%
Debt/Equity N/A
Price/Sales 3.66
Price/Book 53.84
Book Value/Share 0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar